Cargando…
In Vitro Effects of Combining Genistein with Aromatase Inhibitors: Concerns Regarding Its Consumption during Breast Cancer Treatment
Introduction: The third-generation of aromatase inhibitors (AIs)—Exemestane (Exe), Letrozole (Let), and Anastrozole (Ana)—is the main therapeutic approach applied for estrogen receptor-positive (ER+) breast cancer (BC), the most common neoplasm in women worldwide. Despite their success, the developm...
Autores principales: | Bezerra, Patrícia H. A., Amaral, Cristina, Almeida, Cristina F., Correia-da-Silva, Georgina, Torqueti, Maria Regina, Teixeira, Natércia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10343543/ https://www.ncbi.nlm.nih.gov/pubmed/37446555 http://dx.doi.org/10.3390/molecules28134893 |
Ejemplares similares
-
Cannabidiol as a Promising Adjuvant Therapy for Estrogen Receptor-Positive Breast Tumors: Unveiling Its Benefits with Aromatase Inhibitors
por: Almeida, Cristina Ferreira, et al.
Publicado: (2023) -
An Exemestane Derivative, Oxymestane-D1, as a New Multi-Target Steroidal Aromatase Inhibitor for Estrogen Receptor-Positive (ER(+)) Breast Cancer: Effects on Sensitive and Resistant Cell Lines
por: Amaral, Cristina, et al.
Publicado: (2023) -
Cannabinoids in Breast Cancer: Differential Susceptibility According to Subtype
por: Almeida, Cristina Ferreira, et al.
Publicado: (2021) -
Is There Any Cardiovascular Concern Regarding the Use of Aromatase
Inhibitors in Breast Cancer?
por: Galvão, Tatiana F. G.
Publicado: (2019) -
New steroidal aromatase inhibitors: Suppression of estrogen-dependent breast cancer cell proliferation and induction of cell death
por: Cepa, Margarida, et al.
Publicado: (2008)